Leveraging Transcriptomics Data to Refine Immunotherapy Response Prediction in NSCLC: STK11 Deficiency and Beyond.

Autor: Amori G; Division of Pathology, The Cancer Institute, Japanese Foundation for Cancer, Tokyo, Japan; Department of Pathology, The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan., Sugawara E; Division of Pathology, The Cancer Institute, Japanese Foundation for Cancer, Tokyo, Japan; Department of Pathology, The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan., Inamura K; Division of Pathology, The Cancer Institute, Japanese Foundation for Cancer, Tokyo, Japan; Department of Pathology, The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan. Electronic address: kentaro.inamura@jfcr.or.jp.
Jazyk: angličtina
Zdroj: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2023 Nov; Vol. 18 (11), pp. e134-e135.
DOI: 10.1016/j.jtho.2023.08.021
Databáze: MEDLINE